Oruka Therapeutics (ORKA) Misses Q2 EPS by 46c

Oruka Therapeutics (NASDAQ: ORKA) reported Q2 EPS of ($0.46).

For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.

You May Also Be Interested In

• Take-Two stock drops as GTA 6 leaks continue
• Bessent: we are not in war with Canada - CNBC interview
• NIO Inc. (NIO) call put ratio 4.2 calls to 1 put with a focus on September 4.5 and 5 calls into quarter results